Policy paper

2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement

The key terms of the agreement reached between the Department of Health and Social Care, NHS England and the Association of the British Pharmaceutical Industry for a new voluntary scheme.

• From: Department of Health and Social Care
• Published: 20 November 2023

This was published under the 2022 to 2024 Sunak Conservative government

Documents

2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement

HTML

Details

The voluntary scheme will run for 5 years from 1 January 2024. The objectives of the voluntary scheme will be to:

• promote better patient outcomes and a healthier population
• support UK economic growth
• contribute to a financially sustainable NHS

The parties commit to continuing to work together to agree a full scheme document in accordance with the heads of agreement.

Published 20 November 2023